explore -WSS

explore

author：explore 2025-09-30 00:48:04 - browse：84654

Photograph of an abandoned lab with empty bottle, boxes, and beakers all around. -- biotech coverage from STAT — Adobe

SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart.

Three years later, Histogen no longer develops therapies. It has abandoned efforts to reverse baldness, replenish cartilage in achy knees, and quell infection and inflammation.

The company has no lab. It has no headquarters. It has just two employees, including a chief financial officer who also serves as secretary, CEO, and president. Histogen’s stock trades below $1 a share. And even that is coming to a close. On Thursday, the Nasdaq suspended trading of Histogen shares after determining that the company’s operations and assets are negligible, meaning the biotech is now officially a shell of its former self.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Future doctors should be trained to promote social change

focus

Wikipedia

WSS

Medicare proceeds with plan to claw back hospital funds

Future doctors should be trained to promote social change

Key Senate panel to consider PBM, drug pricing reform package

Brain injuries and the importance of a second opinion

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Gene editing the human germline: What are the risks?

hotspot

explore

hotspot

The high cost of giving birth even with insurance

Future doctors should be trained to promote social change

Medicare details structure of new drug price negotiation program

Kidney transplant patients stopped immunosuppressants in trial

Drug repurposing or repositioning? The language matters

Asbestos, a deadly carcinogen, banned by EPA

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Coloradans with cystic fibrosis could lose access to Trikafta

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medicare proceeds with plan to claw back hospital funds

leisure time

Plastic surgeons increase patient psychiatric screenings

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Nurses recount patients attacks

5 to watch: Tech startups trying to solve health care's staffing crisis

Prime Medicine says its gene editing passes test in monkeys

Plastic surgeons increase patient psychiatric screenings

knowledge

focus

Wikipedia

explore